Annual report pursuant to Section 13 and 15(d)

Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)

v3.23.1
Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Net operating loss carryforwards $ 53,842 $ 52,559
Stock-based compensation 3,099 3,006
Federal R&D credit 2,222 2,222
Accrued expenses 101 156
Capitalized research expenses 1,448
Intangibles 347 216
Right of use asset/liabilities 12 3
Other 2 0
Total deferred tax assets 61,073 58,162
Deferred tax liabilities:    
Depreciation (287) (221)
Right of Use Asset/Liabilities
Total deferred tax liabilities (287) (221)
Less valuation allowance (60,786) (57,941)
Net deferred tax liability